Submission argues against the release of information that is currently released

August 16, 2022 Latest News BioPharma News of the Day

This is a preview of subscriber content

Subscribe now to continue reading.

The Department of Health has confirmed the government has no real power to publish information submitted by a sponsor and that it should not release information regarding deliberations on a medicine. …

Subscribe now to continue reading.

Latest Video

Australian study finds maternal RSV vaccination offers strong protection for infants
August 25, 2026 - Latest News
Avecho moves to deepen global partnering push as CBD insomnia program advances
August 24, 2026 - Australian Biotech
Acrux brings experienced clinical leader aboard to advance testosterone program
August 24, 2026 - Australian Biotech
Insurers warn cut could hit Australians most likely to need cancer care
August 25, 2026 - Latest News
Australia cannot deliver meaningful change until the levers of power are rebalanced
August 26, 2026 - Latest News

Submission argues against the release of information that is currently released

This is a preview of subscriber content

Latest Video

Most Read

Australian study finds maternal RSV vaccination offers strong protection for infants

Avecho moves to deepen global partnering push as CBD insomnia program advances

Acrux brings experienced clinical leader aboard to advance testosterone program

Insurers warn cut could hit Australians most likely to need cancer care

Australia cannot deliver meaningful change until the levers of power are rebalanced

New Stories

Cathy Freeman to headline 2026 Patient’s Choice Awards

Australian company secures Mitsubishi partnership to bring BioPQQ to market

Noxopharm pushes Sofra platform towards cancer proof of concept

Argent BioPharma takes CannEpil into US veterinary regulatory process

Entropy takes TRP-8803 to the US in head-to-head depression trial

Neuren’s first dividend signals a new phase built on DAYBUE royalties

Starpharma narrows loss as Genentech deal lifts revenue and new funding extends runway

Sign In

Submission argues against the release of information that is currently released

This is a preview of subscriber content

Latest Video

Most Read

Australian study finds maternal RSV vaccination offers strong protection for infants

Avecho moves to deepen global partnering push as CBD insomnia program advances

Acrux brings experienced clinical leader aboard to advance testosterone program

Insurers warn cut could hit Australians most likely to need cancer care

Australia cannot deliver meaningful change until the levers of power are rebalanced

Follow Us

New Stories

Cathy Freeman to headline 2026 Patient’s Choice Awards

Australian company secures Mitsubishi partnership to bring BioPQQ to market

Noxopharm pushes Sofra platform towards cancer proof of concept

Argent BioPharma takes CannEpil into US veterinary regulatory process

Entropy takes TRP-8803 to the US in head-to-head depression trial

Neuren’s first dividend signals a new phase built on DAYBUE royalties

Starpharma narrows loss as Genentech deal lifts revenue and new funding extends runway